-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on Concentrix, Maintains $54 Price Target

Benzinga·03/27/2025 14:46:42
Listen to the news
Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:CNXC) with a Outperform and maintains $54 price target.